Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.

• Vora AN UPMC Pinnacle, Harrisburg, PA (A.N.V.).
• Alexander JH Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.N.V., J.H.A., D.M.W., C.B.G., D.F.K., R.H.M., R.D.L.).
• Wojdyla DM Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.N.V., J.H.A., D.M.W., C.B.G., D.F.K., R.H.M., R.D.L.).
• Aronson R Bristol-Myers Squibb, Lawrenceville, NJ (R.A.).
• Granger CB Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.N.V., J.H.A., D.M.W., C.B.G., D.F.K., R.H.M., R.D.L.).
• Darius H Vivantes Neukoelln Medical Center, Berlin, Germany (H.D.).
• Windecker S Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland (S.W.).
• Mehran R Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, and Cardiovascular Research Foundation, New York (R.M.).
• Averkov O Pirogov Russian National Research Medical University, Moscow (O.A.).
• Budaj A Department of Cardiology, Grochowski Hospital, Warsaw, Poland (A.B.).
• Kong DF Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.N.V., J.H.A., D.M.W., C.B.G., D.F.K., R.H.M., R.D.L.).
• Kobalava Z RUDN University, Moscow, Russia (Z.K.).
• Mehta RH Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.N.V., J.H.A., D.M.W., C.B.G., D.F.K., R.H.M., R.D.L.).
• Mirza Z Witham Specialist Center, Lebanon, IN (Z.M.).
• Guimaraes PO Instituto do Coração-HCFMUSP, São Paulo, Brazil (P.O.G.).
• Parkhomenko A Emergency Cardiology Department, Institute of Cardiology, Kiev, Ukraine (A.P.).
• Quadros A Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil (A.Q.).
• Thiele H Heart Center Leipzig at University of Leipzig, Germany (H.T.).
• Goodman SG Canadian VIGOUR Center, University of Alberta, Edmonton (S.G.G.).
• Lopes RD Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.N.V., J.H.A., D.M.W., C.B.G., D.F.K., R.H.M., R.D.L.).

Show more…

acute coronary syndrome

anticoagulants

atrial fibrillation

hospitalization

percutaneous coronary intervention

platelet aggregation inhibitors

Acute Coronary Syndrome

Aged

Anticoagulants

Aspirin

Atrial Fibrillation

Cardiovascular Agents

Combined Modality Therapy

Drug Therapy, Combination

Elective Surgical Procedures

Female

Fibrinolytic Agents

Hemorrhage

Hospitalization

Humans

Length of Stay

Male

Middle Aged

Multicenter Studies as Topic

Percutaneous Coronary Intervention

Platelet Aggregation Inhibitors

Proportional Hazards Models

Prospective Studies

Purinergic P2Y Receptor Antagonists

Pyrazoles

Pyridones

Randomized Controlled Trials as Topic

Survival Analysis

Treatment Outcome

Vitamin K